Scleroderma/Raynauds
![](https://pbs.twimg.com/profile_images/1225811658255282178/SJTqzDp5.jpg)
2 years 8 months ago
👌Superb review of #SSc ILD by @sclerodermaUM #ACR21
👉EARLY/SUBCLINICAL is NOT Mild ILD
👉MMF 1st
👉TCZ in combination for progressive phenotype/progression
👉Nintedanib:start slow, uptitrate for GI tolerability
👉Early HSCT referral (early dcSSc, FVC&DLCO 45-80%, Normal🫀) https://t.co/MUOhc3PakH
![](https://pbs.twimg.com/media/FDweLEOXMAU_sB-.jpg)
![](https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN.jpg)
2 years 8 months ago
Prof. Ami Shah: Patients with #scleroderma have an ⬆ risk of #cancer vs. general population
📌Data from 3 recent meta-analysis: Scleroderma pts have 1.4 to 1.8 fold increased risk of cancer
@RheumNow #ACR21 https://t.co/4uQN6y3tIn
![](https://pbs.twimg.com/media/FDy4NpZVgAIn3Zu.png)
![](https://pbs.twimg.com/profile_images/1027501556868870145/2culK0bN.jpg)
2 years 8 months ago
Dr. Ami Shah shares her approach to cancer screening in patients with #scleroderma👇
@RheumNow #ACR21 https://t.co/chmlGe4iyl
![](https://pbs.twimg.com/media/FDy8WM3aIAAYaRH.png)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G.jpg)
2 years 8 months ago
Who declines most with #scleroderma #ILD - early dcSSc, ⬆️CRP, ⬆️mRSS all w more ⤵️FVC. Results verified in SENSIS trial of SSc ILD where #nintedanib was superior to placebo abst#1846 #ACR21 @RheumNow https://t.co/eckUj0qwch
![](https://pbs.twimg.com/media/FDx0kMmX0AQnRgd.jpg)
![](https://pbs.twimg.com/profile_images/1355595340292960263/5lmNF6jH.jpg)
2 years 8 months ago
Dr Ami Shah - Scleroderma & Cancer:
🛑 ⬆️ risk of ca around the time of dx in SSc patients with RNA-pol-III (especially first 5 years after dx), anti-Th/To protective?
🛑Her approach for ca screening in newly diagnosed with SSc pts and red flags as below
#ACR21 #ACRambassador https://t.co/2VcWn2UInm
![](https://pbs.twimg.com/media/FDw-uMRWEAQ5PAN.jpg)
![](https://pbs.twimg.com/profile_images/1007774150000332801/SjLeJk3G.jpg)
2 years 8 months ago
What if a celebrity had #Scleroderma? Would that ⬆️attention & funding for this rare disease? See what Big Bird says @RheumNow #ACR21 ?affected #PetsofACR @RheumNow @scleroderma @SclerodermaCAN audio-13.m4a
![](https://pbs.twimg.com/profile_images/1322922848810422289/oM4qP9_k.jpg)
2 years 8 months ago
#ACR21 Thieves: SLE and SSc with worsening cytopenia and hematuria despite treatment:
Maria Powell - presents overlap case with PNH, responded to eculizumab
@Rheumnow https://t.co/CGvHEMA3lI
![](https://pbs.twimg.com/media/FDwlziQXIAc3d4B.png)
![](https://pbs.twimg.com/profile_images/956713613854584833/7Vo7a2l5.jpg)
2 years 8 months ago
Interesting thoughts from Dr. Distler re:nintedanib & MMF in SSc-ILD
Agree we should look into MMF-nintedanib combo, but this graph makes me think MMF > NIN
Why would that be? Unlike NIN, MMF pts were NOT randomized, which likely favors NIN for a few (speculative) reasons: https://t.co/ZHBD8x74PM
![](https://pbs.twimg.com/media/FDs5zfqXIAULya-.png)